AMO's IntraLase, Carl Zeiss settle patent row:
This article was originally published in Clinica
Executive Summary
Ophthalmic laser rivals Advanced Medical Optics and Carl Zeiss Meditec have signed a non-exclusive US licence related to patented laser technology for eye surgery. AMO's IntraLase subsidiary has granted Carl Zeiss use of its technology, which the Jena, Germany-based firm will use to provide femtosecond technology for corneal surgery. This agreement settles a dispute from last year where IntraLase filed suit against Carl Zeiss in November 2006 over use of confidential information relating to its ultra-fast laser technology (see Clinica No 1232, p 17) - it was subsequently bought by AMO for $808m in April 2007. Terms of the new agreement were not disclosed.